Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up

BACKGROUND: Visual hallucinations are common in patients with Parkinson's disease and represent probably the major independent predictor for cognitive deterioration and nursing home placement. OBJECTIVE: To investigate if treatment of minor visual hallucinations in Parkinson's disease with...

Descripción completa

Detalles Bibliográficos
Autores principales: van Mierlo, Tom J. M., Foncke, Elisabeth M. J., Post, Bart, Schmand, Ben A., Bloem, Bastiaan R., van Harten, Barbera, Tissingh, Gerrit, Munts, Alexander G., de Haan, Rob J., de Bie, Rob M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413762/
https://www.ncbi.nlm.nih.gov/pubmed/34291590
http://dx.doi.org/10.1002/brb3.2257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413762/
https://www.ncbi.nlm.nih.gov/pubmed/34291590
http://dx.doi.org/10.1002/brb3.2257

Ejemplares similares